Home » interviews » Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics

  • November 24, 2025

Interviews

Advances i
Advances in genetic testing, fertility preservation, and ART are reshaping reproductive care across India: Dr. Umesh N Jindal, Director, Jindal IVF
India rema
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex comm
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
View More

Appointments

Hester Biosciences appoints Ashish Desai as CFO
Hester Biosciences appoints Ashish Desai as CFO
Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India
Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India
Zydus Wellness appoints Manish Lal as Head, Global Demand and Supply Organization
Zydus Wellness appoints Manish Lal as Head, Global Demand and Supply Organization
View More

Startup

Teva launches 'Teva Rise' to harness global innovation and transform healthcare
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
Lilly opens biotech in San Diego
Lilly opens biotech in San Diego
View More

Digitization

Mount Sinai to implement Microsoft Dragon Copilot for clinical documentation
Mount Sinai to implement Microsoft Dragon Copilot for clinical documentation
CereCore joins oracle partner network to strengthen healthcare IT and EHR services
CereCore joins oracle partner network to strengthen healthcare IT and EHR services
Nitinotes secures CE mark for automated suturing platform ‘EndoZip’
Nitinotes secures CE mark for automated suturing platform ‘EndoZip’
View More

Latest Stories

Telangana fires up biologics innovation, debuts India's first single-use bioprocess scale-up hub

Brenntag to showcase latest pharma innovation at CPHI India 2025

EU clears Bristol Myers Squibb’s CAR-T therapy Breyanzi for tough-to-treat Lymphoma

Eli Lilly to unveil major breast cancer data at SABCS 2025

Thermo Fisher opens two new centers in Hyderabad

Opinion
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India
From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews
Advances in genetic testing, fertility preservation, and ART are reshaping reproductive care across India: Dr. Umesh N Jindal, Director, Jindal IVF
Advances in genetic testing, fertility preservation, and ART are reshaping reproductive care across India: Dr. Umesh N Jindal, Director, Jindal IVF
Dr. Umesh N Jindal Director, Jindal IVF
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India

Packaging